Clinical Trial Update: A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa [Phase 2]

View source ↗

Summary

Phase 2 trial update for PTR-01 in recessive dystrophic epidermolysis bullosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• PTR-01

Snippet

Sponsor: Phoenix Tissue Repair, Inc. | Conditions: Recessive Dystrophic Epidermolysis Bullosa | Phase 2 | Status: COMPLETED